<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03999541</url>
  </required_header>
  <id_info>
    <org_study_id>#0014</org_study_id>
    <nct_id>NCT03999541</nct_id>
  </id_info>
  <brief_title>Freeze-all Policy in Poor Responders</brief_title>
  <official_title>Fresh Versus Frozen Embryos for Infertility in the Poor Responders as Defined by the Bologna Criteria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Al-Yasmeen Fertility and Gynecology Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Al-Yasmeen Fertility and Gynecology Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the effects of fresh embryo transfers (ET) and elective frozen-thawed embryo
      transfer cycles in poor ovarian responders.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 30, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Blinding of the allocated intervention is not possible.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Livebirth rate</measure>
    <time_frame>32 weeks</time_frame>
    <description>The proportion of women in the population who had at least one live baby.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>2 weeks</time_frame>
    <description>Positive pregnancy test at two weeks +/− three days after embryo transfer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>6-8 weeks</time_frame>
    <description>The presence of at least one fetal heartbeat at ultrasound between six and eight weeks of gestation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">178</enrollment>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>Freeze-all</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Good quality embryos (either day 3 or 5) will be frozen and subsequent frozen embryo transfer will be arranged within three months of the egg retrival.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fresh embryo transfer</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Women will undergo fresh embryo transfer at the cleavage (day 3) or blastocyst stage (day 5).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Freeze-all policy</intervention_name>
    <description>A policy of freezing all the embryos followed by subsequent thawed frozen embryo transfer</description>
    <arm_group_label>Freeze-all</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients that fulfill the Bologna criteria [at least 2 of the following 3 features
             must be present: (i) advanced maternal age or any other risk factor for POR; (ii) a
             previous POR; and (iii) an abnormal ovarian reserve test (ORT)]

          -  if the progesterone serum level was ≤1.5 ng/mL on the trigger day.

          -  body mass index 18-32 kg/m2

          -  Both partners are able to provide written informed consent.

          -  At least 1 good quality embryo on day 3 after egg collection on day 3 according to the
             Istanbul consensus (7-8 cells; with symmetric blastomeres and &lt;10% fragmentation by
             volume).

          -  Endometrial thickness ≥8 mm on trigger day.

          -  a normal uterine cavity on ultrasound.

          -  IVF/ICSI with only fresh semen

        Exclusion Criteria:

          -  Pre-implantation genetic testing is being planned.

          -  if they had severe endometriosis, uterine pathology (myomas, adenomyosis,
             endocrinopathies, adhesions, acquired or congenital abnormalities), untreated tubal
             hydrosalpinges, ovarian tumor, recurrent spontaneous abortion, implantation failure
             after ≥ 2 fresh or frozen ET.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yasmin Magdi, PhD</last_name>
    <phone>00201282313979</phone>
    <email>Yas.magdi@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Al-Yasmeen Fertility and Gynecology Center</name>
      <address>
        <city>Banhā</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yasmin Magdi, Ph.D</last_name>
      <phone>00201282313979</phone>
      <email>Yas.magdi@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>June 22, 2019</study_first_submitted>
  <study_first_submitted_qc>June 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2019</study_first_posted>
  <last_update_submitted>January 25, 2020</last_update_submitted>
  <last_update_submitted_qc>January 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Al-Yasmeen Fertility and Gynecology Center</investigator_affiliation>
    <investigator_full_name>Yasmin Magdi</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

